Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Tilade

Known as: Aventis Behring Brand of Nedocromil Sodium, Pantheon Brand of Nedocromil Sodium, Rhône-Poulenc Rorer Brand of Nedocromil Sodium 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
The electrostatic charge properties of aerosols produced by commercial metered dose inhalers (MDIs), including Ventolin, QVAR… Expand
Review
1995
Review
1995
Comparative clinical trials which include known therapies as well as placebos are essential in constructing a solid basis from… Expand
Highly Cited
1990
Highly Cited
1990
To determine the efficacy of nedocromil sodium in adult asthma patients using bronchodilators alone to control their disease, a… Expand
Highly Cited
1988
Highly Cited
1988
The ability of nedocromil sodium, a new anti‐inflammatory agent for the treatment of asthma, to inhibit activation of human… Expand
1986
1986
Abstract. In a double‐blind group comparative trial nedocromil sodium (Tilade®) at a dose of 4 mg four times daily was compared… Expand
1986
1986
Nedocromil sodium is the disodium salt of a novel pyranoquinoline dicarboxylic acid which has physicochemical and pharmacokinetic… Expand
1986
1986
Nedocromil sodium in a dose of 4 mg b.i.d. or q.i.d. by inhalation was used to treat asthmatic patients in a double-blind… Expand
Highly Cited
1985
Highly Cited
1985
A number of antiallergic pyranquinolinedicarboxylic acid derivatives with potential for the topical treatment of asthma have been… Expand
Highly Cited
1984
Highly Cited
1984
ACADEMIC POSITIONS Distinguished Professor of Economics, Syracuse University, 2005-present. Part-time Chair in Economics… Expand
1983
1983
  • T. Oruene
  • Acta geneticae medicae et gemellologiae
  • 1983
  • Corpus ID: 41360145
The birth of twins was believed by the earlier Yoruba communities to be an omen. Drastic measures were adopted in the form of… Expand